ANI Pharmaceuticals (ANIP) reported $197.12 million in revenue for the quarter ended March 2025, representing a year-over-year increase of 43.4$1.70 for the same period compares to $1.21 a year ago.The reported revenue compares to the Zacks Consensus Estimate of$179.45 million, representing a surprise of +9.85%. The company delivered an EPS surprise of +24.09%, with the consensus EPS estimate being $1.37.While investors closely watch year-over-year changes in headline numbers -- revenue and earni ...